Skip to main content
. 2024 Apr 15;15(4):724–734. doi: 10.4239/wjd.v15.i4.724

Figure 1.

Figure 1

Teneligliptin ameliorated myocardial hypertrophy in streptozotocin-induced diabetic mice. A: Molecular structure of teneligliptin; B: Quantitative analysis of cardiomyocyte area; C: Heart weight/tibia length. aP < 0.05 vs control group; bP < 0.05 vs streptozotocin group, n = 8. STZ: Streptozotocin.